Cryotherapy for recurrent prostate cancer (IPG119)
Fast, easy summary view of NICE guidance on 'prostate cancer'
The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on cryotherapy for recurrent prostate cancer in May 2005.
Further recommendations have been made as part of the clinical guideline on prostate cancer published in February 2008, as follows:
High intensity focused ultrasound (HIFU) and cryotherapy are not recommended for men with localised prostate cancer other than in the context of controlled clinical trials comparing their use with established interventions.
Clinical and cost-effectiveness evidence was reviewed in the development of this guideline which has led to this more specific recommendation. More information is available from www.nice.org.uk/cg58. The IP guidance on cryotherapy for recurrent prostate cancer remains current, and should be read in conjunction with the clinical guideline.
This procedure is used to treat carcinoma of the prostate that has been unsuccessfully treated via another method, most typically radiation or hormones.
The procedure is performed by inserting cryotherapeutic probes into the prostate gland. These are used to freeze the gland along with cancerous tissue, thus destroying the diseased tissue.
Patients are typically given spinal anaesthesia. A warming catheter is inserted into the bladder, which is kept distended and warmed to 38º C and remains in place for two hours following the procedure. Cryoprobes are inserted into the prostate under transrectal ultrasonic guidance.
Thermocouples or temperature monitor probes are placed adjacent to the neurovascular bundles, the apex, Denonvilliers' space and external sphincter. A double freeze-thaw process is initiated with the anterior cryoprobes being activated first, followed by the posterior probes. The aim is to freeze the entire gland. A suprapubic tube is left in place and open for at least 4 days postoperatively.
M70.8 Other specified other operations on outlet of male bladder
Y13.2 Cryotherapy to lesion of organ NOC
In addition the ICD-10 code C61.X Malignant neoplasm of prostate or C79.8 Secondary malignant neoplasm of other specified sites would be recorded.
The NHS Classifications Service of NHS Connecting for Health is the central definitive source for clinical coding guidance and determines the coding standards associated with the classifications (OPCS-4 and ICD-10) to be used across the NHS. The NHS Classifications Service and NICE work collaboratively to ensure the most appropriate classification codes are provided. www.connectingforhealth.co.uk/clinicalcoding
- IPG119 Cryotherapy for recurrent prostate cancer: guidance (web format)
- IPG119 Cryotherapy for recurrent prostate cancer - guidance
- IPG119 Cryotherapy for recurrent prostate cancer - information for people considering the procedure
- Interventional procedure consultation document - salvage cryotherapy for recurrent prostate cancer (second consultation)
- Overview of salvage cryotherapy for recurrent prostate cancer (second consultation)
- Interventional procedure consultation document - secondary transperineal cryotherapy for carcinoma of the prostate
- Overview of secondary transperineal cryotherapy for carcinoma of the prostate
This guidance has been incorporated into the following NICE Pathways, along with other related guidance and products.
Visit the NICE Pathway: prostate cancer
This page was last updated: 19 June 2012
Information for the public
Implementation tools and resources
- None available
See this guidance in practice
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.
The published full clinical guidance for specialists with background, evidence, recommendations and methods used.